Evidence map›Paper›PMID 38196489›Full record

ArticlePakistan journal of medical sciences

Asra Khan Pahore, Shagufta Khan, Nasim Karim

Open access · greenAbstract read
In one paragraph

Article in Pakistan journal of medical sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Preclinical Study of CDH3-TargetedMolecular pharmaceutics · 2026
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Asra Khan PahoreDr. Asra Khan Pahore, BDS, MPhil. Senior Lecturer, Department of Pharmacology, Altamash Institute of Dental Medicine, Karachi, Pakistan.
Shagufta KhanDr. Shagufta Khan, MPhil, Ph.D. Assistant Professor, Department of Biological & Biomedical Sciences, Aga Khan University, Karachi, Pakistan.
Nasim KarimProf. Dr. Nasim Karim, MBBS, MPhil, Ph.D., Post-Doc. Head Department of Pharmacology, Bahria University Medical & Dental College, Karachi, Pakistan.
Aga Khan University · PKBahria University · PKKarachi Medical and Dental College · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the anticancer activity of methanolic extract of Illicium verum against triple-negative breast cancer MDA-MB-231 cell line. Methods: A cell culture experimental study was carried out at Pharmacology department of Bahria University Medical and Dental College (January to June 2021) in collaboration with Aga Khan University, Karachi, Pakistan. Cell viability and proliferation assays were used to quantify dead and alive cells by utilizing a tetrazolium assay and an enzyme immunosorbent plate reader was used to calculate their absorbance. For the apoptosis initiation assay, these cells were dyed with a fluorescent stain and observed for fluorescence and apoptosis. During cell viability testing, various Results: In the cell viability assay, all Conclusion:

Indexed as

ApoptosisCell lineCell survivalIlliciumMethanolTriple negative neoplasms

Identifiers

PMID38196489
PMCPMC10772409
OpenAlexW4390743452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.